Manufacturer: BRITISH DRAGON
Category: Injectable steroids
Substance: boldenone undecylenate
Package: 200 mg/ml (10 ml)
Boldabol (Equipoise, Boldenone Undecylenate) is a derivative of testosterone, that shows strong anabolic and reasonably androgenic resources. The undecylenate ester very much make bigger the doings of the drug, also this clinically shots would want to be did again every three or 4 weeks!
As with every one steroids, this product explains a striking ability to enhancing red blood compartment production.
Current that composite has turn out to be a beloved surrounded by competitors. Many think that it’s an perfect substitute to Deca-Durabolin.
Negative effects of Boldabol (Equipoise, Boldenone Undecylenate) are in general kind. The structure does allow it to convert into estrogen, but it does contain an really increased empathy to act so.
Water preservation with this drug would consequently be somewhat higher that its with Deca-Durabolin, but notably low than we would get with a sturdy composite as Testosterone.
While there is still a ability of encountering an estrogen corresponding Side responses as each of when applying Boldabol (Equipoise, Boldenone Undecylenate), complications are usually not encountered at a reasonable prescribed amount level.
Recommended dosage: 100-500 mg per week.
In the presence of adequate protein and calories, Boldabol promotes body tissue building processes and can reverse catabolism. As these agents are either derived from or are closely related to testosterone, the anabolics have varying degrees of androgenic effect. Boldabol, as well as other anabolic steroids can also stimulate erythropoisis. The mechanism for this effect may occur by stimulating erythropoeitic stimulating factor. Anabolics can cause nitrogen, sodium, potassium and phosphorus retention and decrease the urinary excretion of calcium.
Equipoise is the popularly referenced brand name for the veterinary injectable steroid boldenone undecylenate. Specifically it is a derivative of testosterone, which exhibits strong anabolic and moderately androgenic properties. The undecylenate ester greatly extends the activity of the drug (the undecylenate ester is only one carbon atom longer than decanoate), so that clinically injections would need to be repeated every three or four weeks. In veterinary medicine EquipoiseAc is most commonly used on horses, exhibiting a pronounced effect on lean bodyweight, appetite and general disposition of the animal. This compound is also said to shows a marked ability for increasing red blood cell production, although there should be no confusion that this is an effect characteristic of newly all anabolic/androgenic steroids. The favorable properties of this drug are greatly appreciated by athletes, Equipoise being a very popular injectable in recent years. It is considered by many to be a stronger, slightly more androgenic Deca-Durabolin. It is generally cheaper, and could replace Deca in most cycles without greatly changing the end result.
As discussed earlier, Equipoise is a very versatile compound. We can create a number of drug combinations with it depending on the desired result. For mass, one may want to stack it with Anadrol or an injectable testosterone. The result should be an incredible gain of muscle size and strength, without the same intensity of side effects if using the androgen (at a higher dose) alone. When used in a cutting cycle, muscle hardness and density can be greatly improved when combining Equipoise with a non-aromatizable steroid such as trenbolone acetate, Halotestin, or Winstrol. For some however, even the low buildup of estrogen associated with this compound is enough to relegate its use to bulking cycles only.
Boldenone is not an ideal steroid for the drug tested athlete however. This drug has the tendency to produce detectable metabolites in the urine months after use, a worry most commonly associated with Deca-Durabolin. This is of course due to the high oil solubility of long chain esterified injectable steroids, a property which enables the drug to remain deposited in fatty tissues for extended periods of time. While this will reliably slow the release of steroid into the blood stream, it also allows small residual amounts to remain present in the body far after the initial injection. The release of stubborn stores of hormone would no doubt also be enhanced around contest time, a period when the athlete drastically attempts to mobilize unwanted body fat. If enough were used in the off-season, the athlete may actually fail a drug screen for boldenone although many months may have past since the drug was last injected.